AVROBIO Inc

Appili Therapeutics, nestled in the vibrant city of Toronto, ON, stands as a beacon of innovation in the realm of biotechnology. This cutting-edge company thrives on the pulse of scientific advancement, where minds converge to unravel the mysteries of medicine and push the boundaries of healthcare. Within the walls of Appili Therapeutics, a symphony of intellect and curiosity harmonizes to pave the way for groundbreaking discoveries. Here, scientists and visionaries collaborate tirelessly, driven by the shared mission to revolutionize treatment options and improve the quality of life for countless individuals worldwide. Toronto's very own Appili Therapeutics is a testament to the relentless pursuit of excellence in the ever-evolving landscape of biotechnology. Generated using this place's available information

Notch Therapeutics, founded in 2018 and based in Toronto, is pioneering the development of advanced T cell therapies through its innovative UNiTCell, derived from induced pluripotent stem cells (iPSCs). This off-the-shelf solution aims to address key challenges in adoptive cell therapy, providing a cost-effective and accessible option for a broader range of patients. The company's approach focuses on creating uniform and consistent T cell therapies that can be delivered at the time of diagnosis, enhancing patient experience and treatment accessibility. Notch's proprietary manufacturing methods enable the production of potent and persistent cell therapies, demonstrating robust tumor control and significant potential for improving outcomes in cancer treatment. Generated from the website

Canada's #1 Cord Blood Program